<DOC>
	<DOCNO>NCT01023113</DOCNO>
	<brief_summary>Lacunae Knowledge No study available literature regard visual field impairment proliferative diabetic retinopathy compare conventional double frequency Nd : YAG panretinal photocoagulation PASCAL panretinal photocoagulation AIMS &amp; OBJECTIVE 1 . To compare visual field impairment conventional double frequency Nd : YAG panretinal photocoagulation PASCAL panretinal photocoagulation . 2 . To examine effect modality laser macular edema 60 eye proliferative diabetic retinopathy undergo humphery visual field analysis , optical coherence tomography panretinal photocoagulation</brief_summary>
	<brief_title>To Compare Visual Field Impairment Conventional Double Frequency Nd : YAG Panretinal Photocoagulation With PASCAL Panretinal Photocoagulation</brief_title>
	<detailed_description>Material Methods 1.Study prospective randomize interventional case series . Methods : 60 eye proliferative diabetic retinopathy ( clear medium vitreous/significant preretinal hemorrhage ) take study , 30 eye undergo panretinal photocoagulation conventional frequency double Nd : YAG laser remain 30 eye PASCAL laser . All patient undergo routine ophthalmic examination ( visual acuity , slit lamp , indirect ophthalmoscope , IOP ) well FFA/seven field fundus photo ( whenever require ) , OCT ( optoview spectral domain OCT ) , visual field ( Humphrey 30-2 SITA Standard 60-1 ) baseline blood investigation do 1st sit laser . Written inform consent take subject . PRP complete 2-3 sit 3 day interval one spots apart moderate intensity gray burn give arcade periphery . In case clinical significant macular edema modify grid/ focal laser mild intensity spot do . At visit patient assess visual acuity , OCT , IOP ( applanation tonometer ) . Patients follow least 3 month . After completion last sitting photocoagulation , follow-up one month 3 month . At one month follow together routine ophthalmic examination , OCT , HVF 30-2,60-1 do . At final follow-up 3 month HVF 30-2,60-1 , OCT do addition routine ophthalmic examination FFA do whenever indicate . Inclusion Criteria 1 . 60 eye diabetic patient proliferative DR include . 2 . Visual acuity 20/50 good patient . 3 . Patients available follow least twice 4-12 week . 4 . Patients give consent panretinal photocoagulation inclusion study Exclusion Criteria 1 . Patients diseases known affect visual ﬁeld aphakia , cataract , glaucoma , optic nerve macular disease , exclude study . 2 . Previous photocoagulation ( macular laser PRP ) also exclusion criterion . Out come Measure 1 . Comparison two method relation visual field loss ( previous study average deterioration visual field ( MD ) 3-5dB 45 % case ) term MD , CPSD quadrants loss field number patient worsen visual field method superior term less visual field loss . 2 . Effect macular edema term OCT thickness</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<criteria>1 . 60 eye diabetic patient proliferative DR include . 2 . Visual acuity 20/50 good patient . 3 . Patients available follow least twice 412 week . 4 . Patients give consent panretinal photocoagulation inclusion study 1 . Patients diseases known affect visual ﬁeld aphakia , cataract , glaucoma , optic nerve macular disease , exclude study . 2 . Previous photocoagulation ( macular laser PRP ) also exclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Diabetic retinopathy</keyword>
	<keyword>laser</keyword>
	<keyword>field loss</keyword>
	<keyword>macular edema</keyword>
	<keyword>Visual field loss</keyword>
</DOC>